Tranexamic Acid During Colonic Endoscopic Resection Procedures

Summary

Colonoscopy with polypectomy reduces the incidence and mortality associated with colon cancer. However, polypectomy is associated with adverse events such as bleeding. Tranexamic acid (TXA) is a synthetic derivative of lysine that exerts antifibrinolytic effects and may prevent bleeding. The investigators aim to evaluate the effect of local TXA on preventing intraprocedural and postprocedural bleeding in patients undergoing endoscopic mucosal resection (EMR) of large colon polyps.

Eligibility

Inclusion Criteria:

* Patients referred for endoscopic resection of non-neoplastic and neoplastic lesions in the colon presenting to our tertiary academic center.
* Age \> 18 years

Exclusion Criteria:

* patients with histories of allergic reactions to TXA
* history of seizures
* pregnancy

Conditions2

Interventions2

Related trials

• Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial — RenJi Hospital
• Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia — University of Manitoba
• Perioperative Treatment With Tranexamic Acid in Melanoma — University of Aarhus
• Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial) — Ottawa Hospital Research Institute
• Tranexamic Acid Use for Bleeding Prevention in the Surgical Treatment of Metastatic Spinal Tumor in Lung Cancer Patients — Second Affiliated Hospital, School of Medicine, Zhejiang University
• The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients — Stanford University
• A Randomized Controlled Trial of Inhaled Tranexamic Acid for the Treatment of Pulmonary Hemorrhage in Cancer Patients — M.D. Anderson Cancer Center
• Role of TXA in Patients Undergoing Breast Free Flap Reconstruction — University of Virginia

Browse More Trials